TipRanks
Advertisement
Advertisement

HK:2637 Stock Latest News

Haixi Pharma Reports Encouraging HX9428 Data in nAMD Trials
Company AnnouncementsHaixi Pharma Reports Encouraging HX9428 Data in nAMD Trials
20d ago
2637
Haixi Pharmaceuticals Advances Oral Retinal Drug HX9428 With New DME Trial Plan
PremiumCompany Announcements
Haixi Pharmaceuticals Advances Oral Retinal Drug HX9428 With New DME Trial Plan
1M ago
2637
Fujian Haixi Pharmaceuticals Lifts Revenue as R&D Pipeline Enters Intensive Harvest Phase
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Lifts Revenue as R&D Pipeline Enters Intensive Harvest Phase
1M ago
2637
Haixi Pharma’s Oral Eye Drug HX9428 Wins U.S. FDA Fast Track Status
PremiumCompany Announcements
Haixi Pharma’s Oral Eye Drug HX9428 Wins U.S. FDA Fast Track Status
2M ago
2637
Fujian Haixi Pharmaceuticals Board Sets Date to Approve Interim Results and Mull Dividend
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Board Sets Date to Approve Interim Results and Mull Dividend
2M ago
2637
Fujian Haixi Pharmaceuticals shifts auditor as it adopts Chinese accounting standards
PremiumCompany AnnouncementsFujian Haixi Pharmaceuticals shifts auditor as it adopts Chinese accounting standards
2M ago
2637
Haixi Pharmaceuticals Advances Oral nAMD Drug HX9428 With U.S. FDA Nod and New China Trial
Premium
Company Announcements
Haixi Pharmaceuticals Advances Oral nAMD Drug HX9428 With U.S. FDA Nod and New China Trial
2M ago
2637
Fujian Haixi Pharma Shareholders Back Auditor Switch and New Executive Director
Premium
Company Announcements
Fujian Haixi Pharma Shareholders Back Auditor Switch and New Executive Director
2M ago
2637
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
2M ago
2637
Fujian Haixi Pharmaceuticals Details Significant 2025 Investment Portfolio
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Details Significant 2025 Investment Portfolio
2M ago
2637
Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role
PremiumCompany Announcements
Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role
3M ago
2637
Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance
3M ago
2637
Fujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director
PremiumCompany AnnouncementsFujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director
3M ago
2637
Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China
Premium
Company Announcements
Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China
3M ago
2637
Haixi Pharma Wins NMPA Clearance for New Glioblastoma Drug HXP089
Premium
Company Announcements
Haixi Pharma Wins NMPA Clearance for New Glioblastoma Drug HXP089
3M ago
2637
Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
PremiumCompany Announcements
Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
3M ago
2637
Haixi Pharma Initiated at Buy on Innovative Retinal and Oncology Pipeline; DCF‑Backed Target Price Set at HK$280
PremiumRatings
Haixi Pharma Initiated at Buy on Innovative Retinal and Oncology Pipeline; DCF‑Backed Target Price Set at HK$280
4M ago
Fujian Haixi Pharmaceuticals Overhauls Governance as Shareholders Back All AGM Resolutions
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Overhauls Governance as Shareholders Back All AGM Resolutions
4M ago
2637
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
4M ago
2637
Fujian Haixi Pharma AGM to Vote on Governance Overhaul, New Board and Incentive Plan
PremiumCompany AnnouncementsFujian Haixi Pharma AGM to Vote on Governance Overhaul, New Board and Incentive Plan
5M ago
2637
Fujian Haixi Pharma Proposes H-Share Incentive Scheme for Core Staff
Premium
Company Announcements
Fujian Haixi Pharma Proposes H-Share Incentive Scheme for Core Staff
5M ago
2637
Fujian Haixi Pharmaceuticals Delivers Double-Digit Profit Growth in 2025
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Delivers Double-Digit Profit Growth in 2025
6M ago
2637

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >